Search results for

Facebook's Oversight Board sent the decision of whether to let the former president back on the platform back to the company itself, and it's a critical one for Trump's political future.

More than 500 companies submitted applications for 6.5 million vaping products to the FDA. The agency ruled on some of them but did not yet make a decision on products made by Juul.

A leaked CDC document compared it to the highly contagious children's disease. Data does not support this claim. Nonetheless, the variant is one of the world's most contagious respiratory diseases.

The U.S. economy grew 6.5% pace in the April-June quarter, continuing to strengthen from the worst of the pandemic. A slowdown is inevitable; the question is how much it will slow.

Larry Householder's arrest is tied to a racketeering conspiracy, a spokesperson for the federal prosecutor's office said. Four others, including Ohio's former GOP chairman, were also arrested.

The U.S. stock of flu vaccine was cut nearly in half Tuesday as Britain shut down a major vaccine supplier. Facing a record shortage, authorities are urging healthy Americans to defer getting shots so that medication will be available for those most at risk. Hear NPR's Melissa Block and Dr. Jerry Avorn of the Harvard Medical School.

Can you call the events of Jan. 6 an insurgency? NPR's Lulu Garcia-Navarro asks retired U.S. Army Lt. Gen. Mark Hertling what he thinks based on his experiences in Iraq.

Mitch McConnell said that former President Donald Trump is not immune from criminal and civil litigation. NPR's Steve Inskeep asks Michael McConnell, a constitutional scholar, how that could work.

Below the surface of the sprawling, modern metropolis is a different world. Archaeologists are gaining insights into the city's ancient past by examining the basements of ordinary buildings.

As if the pandemic weren't enough, people are wondering whether climate change will cause pathogens buried in frozen ground to come back to life as the Arctic warms. How worried should we be?